Okeiro
AI Healthcare
Precision medicine, transplant monitoring, clinical decision support
Series A
Okeiro is a Paris-based precision medicine and AI healthcare company focused on transplant patients and people with advanced chronic diseases. Its platform uses validated predictive algorithms and multidimensional clinical data to support remote monitoring, clinical decision-making, and research, with applications across kidney, cardiac, liver, and pulmonary insufficiencies. The company is known for products such as Apilife and Predigraft, and for its iBox predictive algorithm used in transplant care and clinical trials.
Company Details
- Website
- okeiro.com
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2023
- Funding
- €10M ($10.9M)
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring